149 related articles for article (PubMed ID: 17312667)
41. Polyaspartoyl l-arginine protects endothelial cells against injury.
Jian Y; Tang Z; Wang Y; Peng S
Eur J Pharmacol; 2008 Dec; 599(1-3):96-101. PubMed ID: 18854183
[TBL] [Abstract][Full Text] [Related]
42. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
Gong J; Lao XJ; Zhang SJ; Chen S
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
[TBL] [Abstract][Full Text] [Related]
43. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
[TBL] [Abstract][Full Text] [Related]
44. Tubular and glomerular L-arginine transport (uptake and transporters) and the nitric oxide synthases in ischemic acute renal failure (iARF) in streptozotocin-induced diabetic rats (STZ-DM).
Levin-Iaina N; Schwartz I; Chernichovsky T; Davidovitch A; Iaina A; Schwartz D
Ren Fail; 2007; 29(8):1031-8. PubMed ID: 18067052
[TBL] [Abstract][Full Text] [Related]
45. Chronic dietary L-arginine down-regulates adenosine receptor and nitric oxide synthase expression in rat heart.
Rose'Meyer RB; Harrison GJ; Fenning A; Jenner TL; Brown L
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):459-65. PubMed ID: 18312494
[TBL] [Abstract][Full Text] [Related]
46. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
[TBL] [Abstract][Full Text] [Related]
47. The role of the L-arginine-nitric oxide pathway in preeclampsia.
López-Jaramillo P; Arenas WD; García RG; Rincon MY; López M
Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):261-75. PubMed ID: 19124426
[TBL] [Abstract][Full Text] [Related]
48. Elimination of cardiac arrhythmias using oral taurine with l-arginine with case histories: Hypothesis for nitric oxide stabilization of the sinus node.
Eby G; Halcomb WW
Med Hypotheses; 2006; 67(5):1200-4. PubMed ID: 16797868
[TBL] [Abstract][Full Text] [Related]
49. Effect of ocular hypertension on retinal nitridergic pathway activity.
Belforte N; Moreno MC; Cymeryng C; Bordone M; Keller Sarmiento MI; Rosenstein RE
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2127-33. PubMed ID: 17460271
[TBL] [Abstract][Full Text] [Related]
50. Chronic exercise reduces platelet activation in hypertension: upregulation of the L-arginine-nitric oxide pathway.
de Meirelles LR; Mendes-Ribeiro AC; Mendes MA; da Silva MN; Ellory JC; Mann GE; Brunini TM
Scand J Med Sci Sports; 2009 Feb; 19(1):67-74. PubMed ID: 18248541
[TBL] [Abstract][Full Text] [Related]
51. Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
Jin L; Caldwell RB; Li-Masters T; Caldwell RW
J Physiol Pharmacol; 2007 Jun; 58(2):191-206. PubMed ID: 17622691
[TBL] [Abstract][Full Text] [Related]
52. L-arginine in cardiovascular disease: dream or reality?
Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
[TBL] [Abstract][Full Text] [Related]
53. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
Herbaczyńska-Cedro K
J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015
[TBL] [Abstract][Full Text] [Related]
54. Arginine: Clinical potential of a semi-essential amino acid.
Appleton J
Altern Med Rev; 2002 Dec; 7(6):512-22. PubMed ID: 12495375
[TBL] [Abstract][Full Text] [Related]
55. Oral L-arginine administration does not inhibit thrombosis on an experimental model of arterial thrombosis: the effect on the apyrasic activity of the arterial wall.
Iturry-Yamamoto GR; Battastini AM; Martins NL; Edelweiss MI; Sarkis JJ; Ribeiro JP; Picon PD
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):437-44. PubMed ID: 16905946
[TBL] [Abstract][Full Text] [Related]
56. L-Arginine supplementation in sepsis: beneficial or harmful?
Kalil AC; Danner RL
Curr Opin Crit Care; 2006 Aug; 12(4):303-8. PubMed ID: 16810039
[TBL] [Abstract][Full Text] [Related]
57. Arginine nutrition and cardiovascular function.
Wu G; Meininger CJ
J Nutr; 2000 Nov; 130(11):2626-9. PubMed ID: 11053497
[TBL] [Abstract][Full Text] [Related]
58. [Role of the L-arginine-NO system in the prevention and treatment of cardiovascular diseases in pregnant women].
Vladymyrov OA; Tofan NI
Fiziol Zh (1994); 2003; 49(2):73-8. PubMed ID: 12945118
[TBL] [Abstract][Full Text] [Related]
59. L-arginine in the management of cardiovascular diseases.
Cheng JW; Baldwin SN
Ann Pharmacother; 2001 Jun; 35(6):755-64. PubMed ID: 11408995
[TBL] [Abstract][Full Text] [Related]
60. Cardiovascular dysfunction of sepsis: a nitric oxide- and l-arginine-deficient state?
Marik PE
Crit Care Med; 2003 Mar; 31(3):971-3. PubMed ID: 12627015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
